3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
60
Active not recruiting
28
Not yet recruiting
15
Completed
8
Terminated
2
Suspended
2
Withdrawn
1
Enrolling by invitation
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Carcinoma, Non-Small-Cell Lung
1
Interventions
Educational Status
7
Standard of Care
5
Interviews as Topic
5
Cisplatin
5
Blood Specimen Collection
5
Oxaliplatin
4
Surveys and Questionnaires
3
Surgical Procedures, Operative
3
Specimen Handling
3
Patient Navigation
3
Observation
3
Nivolumab
3
Methods
3
Magnetic Resonance Imaging
3
Fluorouracil
3
Early Intervention, Educational
3
Dexamethasone
3
Carboplatin
3
Biopsy
3
toripalimab
2
sacituzumab govitecan
2
pembrolizumab
2
lenvatinib
2
Transcutaneous Electric Nerve Stimulation
2
Radiosurgery
2
Practice Guidelines as Topic
2
Platinum Compounds
2
Paclitaxel
2
Music Therapy
2
Magnetic Resonance Spectroscopy
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Enrolling by invitation
×
trastuzumab deruxtecan
×
1 year
×
Clear all
NCT06250777
2026-02-09
ELPIS
Yonsei University
Phase 2
Enrolling by invitation
27 enrolled